Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gentian Diagnostics ASA ( (DE:6FK) ) has provided an announcement.
Carpe Diem Afseth AS has acquired 10,000 shares in Gentian Diagnostics ASA, bringing its total ownership to 5.01% of the company’s issued shares and voting rights. This acquisition highlights Carpe Diem’s growing interest in Gentian, potentially impacting the company’s shareholder dynamics and market perception.
More about Gentian Diagnostics ASA
Average Trading Volume: 9,697
Current Market Cap: NOK879.1M
For an in-depth examination of 6FK stock, go to TipRanks’ Stock Analysis page.